Senate, House Committees Release Opioid Legislation

Apr 05, 2018 - 02:48 PM
opioid legislation sign

The leaders of the Senate Health, Education, Labor and Pensions Committee last night released a discussion draft of bipartisan legislation to address the opioid crisis, and announced an April 11 hearing on the bill with the goal of marking up legislation this spring. According to a committee summary, the Opioid Crisis Response Act would allow the Food and Drug Administration to require drug makers to package certain opioids for a set duration and provide simple and safe opioid disposal options, and provide support to improve state prescription drug monitoring programs. It also would authorize grants to create comprehensive opioid recovery centers, implement state safe care plans for substance-exposed infants, train first responders to administer opioid overdose drugs, and address workforce shortages, among other provisions. In other news, the House Energy and Commerce Health Subcommittee yesterday announced an April 11 hearing to consider more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies.

Related News Articles

Headline
KFF: Medicare spent 27% more for people who disenrolled from MA than those continuously in Traditional Medicare
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
Bipartisan letter calling for prevention of Medicaid DSH cuts gets signatures from 182 members of Congress
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
AHA responds to Medicare $2 Drug List Model request for information
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
AHA supports physician reimbursement, alternative payment model incentives in comments to MedPAC
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
CMS announces two drug manufacturers to participate in CGT Access Model 
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
CMS releases proposed rule for 2026 Medicare Advantage, prescription drug plans
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026.…